Longs Drug Stores (LDG) Reports May Revenues
Tweet
Share
E-mail
Longs Drug Stores Corporation (NYSE: LDG) reported preliminary total revenues of $401.1 million for the four-week period ended May 25, 2006, a 10.1% increase from total revenues of $364.4 million in the comparable period a year ago.
Preliminary May retail drug store sales were $374.5 million, an increase of 3.6% from $361.5 million in the comparable period last year.
Pharmacy sales were 50.2% of total drug store sales compared with 48.3% a year ago. Retail drug store same-store sales increased 2.9% compared with last year. Pharmacy same-store sales increased 7.0% and front-end same-store sales decreased 0.9%
Preliminary May retail drug store sales were $374.5 million, an increase of 3.6% from $361.5 million in the comparable period last year.
Pharmacy sales were 50.2% of total drug store sales compared with 48.3% a year ago. Retail drug store same-store sales increased 2.9% compared with last year. Pharmacy same-store sales increased 7.0% and front-end same-store sales decreased 0.9%
You May Also Be Interested In
- Exchange Bank declares Q3 dividend, CEO to retire in 2027
- Deere conference call: 2027 orders up mid-single digits from last year)
- Morgan Stanley raises MLCC forecast on Japan output data
Create E-mail Alert Related Categories
Retail SalesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
